phenyl acetate has been researched along with Diabetic Nephropathies in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PP; Hu, ZB; Huang, SJ; Li, XQ; Liu, BC; Lu, CC; Lu, J; Ma, KL; Ruan, XZ; Yuan, BY; Zhang, JX | 1 |
| Chen, PP; Hong, ZH; Hu, ZB; Huang, SJ; Li, XQ; Liu, BC; Lu, CC; Lu, J; Ma, KL; Ruan, XZ; Wang, R; Yuan, BY; Zhang, JX | 1 |
| Fu, J; Liu, L; Wang, LP; Xiu, ZM; Xu, J | 1 |
| An, L; Chen, J; Hu, XW; Li, P; Marikar, FMMT; Miao, QY; Zhou, M | 1 |
| Chung, S; Gagnon, L; Grouix, B; Harris, RC; Laurin, P; Leduc, M; Li, Y; Li, Z; Overstreet, JM; Zhang, MZ | 1 |
| Advani, A; Advani, SL; Azizi, PM; Batchu, SN; Bowskill, BB; Brijmohan, AS; Lee, WL; Liu, Y; Majumder, S; Thai, K; White, KE | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Ala-Korpela, M; Forsblom, C; Groop, PH; Ingman, P; Kaski, K; Mäkinen, VP; Parkkonen, M; Soininen, P | 1 |
| Hampl, H; Kessel, M; Mahiout, A | 1 |
| Hampi, H; Kessel, M; Mahiout, A | 1 |
| Hansen, AP; Hansen, HE; Orskov, H; Schmitz, O | 1 |
| Alberti, KG; Hansen, AP; Hansen, HE; Orskov, H; Schmitz, O | 1 |
| Chiao, PC; Gross, MD; Humes, HD; Schwaiger, M; Shreve, P | 1 |
| Fox, SD; Henderson, LW | 1 |
| Bolzani, R; Galli, G; Navino, C; Panzetta, G; Verzetti, G | 1 |
| Akanji, AO; Sacks, S | 1 |
3 trial(s) available for phenyl acetate and Diabetic Nephropathies
| Article | Year |
|---|---|
Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Topics: Acetates; Acrylic Resins; Acrylonitrile; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Urea Nitrogen; Body Fluids; Body Temperature; Cations; Diabetic Nephropathies; Diabetic Neuropathies; Hemodialysis Solutions; Hemodynamics; Hemofiltration; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis; Weight Loss | 1993 |
Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study.
Topics: Acetates; Adult; Aged; Bicarbonates; Cross-Over Studies; Diabetic Nephropathies; Female; Hemodiafiltration; Humans; Male; Middle Aged; Renal Dialysis | 1998 |
Effect of acetate on blood metabolites and glucose tolerance during haemodialysis in uraemic non-diabetic and diabetic subjects.
Topics: Acetates; Adult; Blood Glucose; Diabetic Nephropathies; Fatty Acids, Nonesterified; Glucose Tolerance Test; Glycerol; Hemodialysis Solutions; Humans; Insulin; Ketone Bodies; Lactates; Male; Middle Aged; Pyruvates; Renal Dialysis; Uremia | 1991 |
13 other study(ies) available for phenyl acetate and Diabetic Nephropathies
| Article | Year |
|---|---|
Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis.
Topics: Acetates; Animals; Cell Line; Cholesterol; Diabetic Nephropathies; Dysbiosis; Gastrointestinal Microbiome; Homeostasis; Humans; Male; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2020 |
Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
Topics: Acetates; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dysbiosis; Gastrointestinal Microbiome; Kidney; Male; Rats, Sprague-Dawley; Renin-Angiotensin System | 2020 |
1-Acetyl-5-phenyl-1H-pyrrol-3-ylacetate: An aldose reductase inhibitor for the treatment of diabetic nephropathy.
Topics: Acetates; Aldehyde Reductase; Animals; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Molecular Structure; Pyrroles; Rats; Streptozocin; Structure-Activity Relationship | 2017 |
Salvia miltiorrhiza Lipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2.
Topics: Acetates; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Gene Expression; Heme Oxygenase-1; Kelch-Like ECH-Associated Protein 1; Male; Membrane Proteins; Mesangial Cells; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Phytotherapy; Plant Extracts; Reactive Oxygen Species; Salvia miltiorrhiza; Streptozocin | 2017 |
Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control.
Topics: Acetates; Animals; Blood Glucose; Diabetic Nephropathies; Disease Models, Animal; Fatty Acids; Fibrosis; Kidney; Membrane Proteins; Mice; Receptors, Cell Surface | 2018 |
Prostaglandin I2 Receptor Agonism Preserves β-Cell Function and Attenuates Albuminuria Through Nephrin-Dependent Mechanisms.
Topics: Acetamides; Acetates; Animals; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Mutation; Phosphorylation; Podocytes; Prodrugs; Protein Processing, Post-Translational; Pyrazines; Receptors, Epoprostenol; Renal Insufficiency; RNA Interference | 2016 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death.
Topics: Acetates; Adult; Albuminuria; Antihypertensive Agents; Apolipoproteins B; Biomarkers; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lactic Acid; Metabolic Syndrome; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Protons; Reproducibility of Results; Triglycerides; Urea | 2008 |
[Pathophysiologic aspects in the treatment of diabetic patients during acetate and bicarbonate dialysis].
Topics: Acetates; Adult; Bicarbonates; Carbon Dioxide; Diabetic Nephropathies; Hemodynamics; Humans; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis | 1984 |
Acid base values, hypoxemia in diabetic patients on acetate and bicarbonate dialysis.
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Carbon Dioxide; Diabetic Nephropathies; Humans; Hypoxia; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis | 1984 |
Inhibition of arginine- and hypoglycemia- induced growth hormone release by acetate in dialyzed patients.
Topics: Acetates; Adult; Aged; Arginine; Diabetic Nephropathies; Female; Growth Hormone; Humans; Hypoglycemia; Male; Middle Aged; Renal Dialysis; Uremia | 1982 |
Acetate suppresses growth hormone secretion in uremic patients: hemodialysis and acetate infusion experiments.
Topics: Acetates; Adult; Arginine; Blood Glucose; Depression, Chemical; Diabetic Nephropathies; Female; Growth Hormone; Humans; Infusions, Parenteral; Male; Middle Aged; Renal Dialysis; Stimulation, Chemical; Uremia | 1982 |
Carbon-11-acetate PET imaging in renal disease.
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Diabetic Nephropathies; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Middle Aged; Renal Artery Obstruction; Tomography, Emission-Computed | 1995 |